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Jin Won Lee, Eun Young Kim, Han Mo Yoo, Cho Hyun Park and Kyo Young Song*Abstract
Background: We investigated the changes of lipid profiles after radical gastrectomy.
Methods: We analyzed the lipid-profile changes after radical gastrectomy in 144 patients with gastric cancer. Their
lipid profiles, including total cholesterol (TC), triglyceride (TG), LDL-cholesterol (LDL), and HDL-cholesterol (HDL),
were evaluated preoperatively as well as 6 and 12 months postoperatively. We compared the changes of lipid
profile according to the reconstruction type and resection extent.
Results: The TC level had decreased 6 months after surgery, and remained unchanged thereafter. The LDL level
also had decreased 6 months after surgery, but had increased again after 12 months after surgery. The HDL level
had increased 12 months after surgery, whereas the TG level was unchanged. In a comparison of the lipid levels
according to the reconstruction type or resection extent, the HDL level significantly differed by reconstruction type
12 months after surgery: it was markedly higher in the total gastrectomy than in the subtotal gastrectomy group
both 6 months and 12 months after surgery. Both the male gender and total gastrectomy were associated with
probability of normalization of LDL after surgery.
Conclusions: The lipid profiles including the TC, LDL and HDL levels were changed after radical gastrectomy;
therefore, after this procedure, the lipid profiles of patients with hyperlipidemia should be evaluated.
Keywords: Lipid profile, Gastrectomy, Gastric cancer, Weight lossBackground
Despite falling incidence rates, gastric cancer remains the
most common malignancy in Korea and Japan [1]. Surgical
resection is the mainstay for cure of patients with gastric
cancer; the gastric volume reduction entailed in radical gas-
trectomy, however, leads to nutritional or metabolic distur-
bances [2] and impinges negatively on overall quality of life.
The possible mechanisms of these problems have been
known to include impaired food intake, malabsorption, im-
paired transit time, and decreased ghrelin levels. Gastric re-
section renders the mixing of food contents with digestive
enzymes difficult, and curtails, thereby, lipid absorption.
The consequently decreased food intake leads to weight
loss, and human body expends proteins and lipid as supple-
mental sources of energy.
Changes in lipid profiles after bariatric surgeries for mor-
bid obesity have been well established in clinical studies* Correspondence: skys9615@gmail.com
Department of Surgery, Seoul St. Mary’s Hospital, The Catholic University of
Korea, College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701,
Korea
© 2015 Lee et al.; licensee BioMed Central. Th
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.[3-8]. It has been shown that bariatric surgeries such as gas-
tric banding, sleeve gastrectomy or Roux-en-Y gastric by-
pass provide effective remission of both morbid obesity and
hyperlipidemia [2,3,5,9,10]. Lipid-profile changes are known
to be associated with weight loss, malabsorption, decreased
caloric intake, altered intestinal transit time, hormonal
change, and diarrhea [11-14]. Such changes after gastrec-
tomy for gastric cancer, however, have received relatively
scant research attention. Lee et al. [2] found that cancer pa-
tients who had undergone gastric resection manifested
lipid-profile, glucose-level and body-weight changes.
In the present study, therefore, we investigated the
changes of lipid profiles after radical gastrectomy. The
correlations of weight change and serum glucose level
with lipid-profile change were also examined. According
to our hypothesis that treatment type can determine
changes of lipid profile, we evaluated the lipid profiles be-
tween different the different patient groups according to
the type of reconstruction and the extent of resection.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Patients and data collection
A total of 144 patients who had undergone curative rad-
ical gastrectomy at our hospital between 2011 and 2012
were enrolled. A complete evaluation including physical
examinations, blood tests, chest and abdominal x-rays,
upper-gastrointestinal endoscopy, endoscopic ultrasound,
abdominal computed tomography and positron emission
scanning was conducted both before and after surgery.
Blood sampling following overnight fasting was performed
to measure the total cholesterol (TC), triglyceride (TG),
low-density lipoprotein (LDL), and high-density lipopro-
tein (HDL) lipid profiles preoperatively as well as 6 months
and 12 months after surgery. Clinical data on age, gender,
body mass index (BMI), stage, comorbidities, the oper-
ation types, and the extent of resection were reviewed.
The patients were divided into groups corresponding to
both the extent of resection and the types of reconstruc-
tion, and the lipid-level changes among them were com-
pared. Additionally, to elucidate the possible correlative
clinicopathological factors leading to lipid-profile change,
changes in body mass index (BMI) and fasting blood sugar
(FBS) were analyzed preoperatively as well as 6 and
12 months after surgery. The resection extent was selected
according to the Japanese gastric cancer treatment guide-
lines [15], which specify subtotal gastrectomy when a sat-
isfactory proximal resection margin can be obtained, and
total gastrectomy when tumors are located on the prox-
imal side or along the greater curvature and harbor metas-
tasis to the No.4sb lymph node. The reconstruction types,
meanwhile, included Billroth I or II and Roux-en-Y. Fi-
nally the relationships between the metabolic parameters
and the perioperative clinical factors were analyzed. Ap-
proval for this study was obtained from our Institutional
Review Broad (IRB KC14RISI0482).
Post-gastrectomy diet schedule
We have critical pathway including diet schedule after
radical gastrectomy for patients with gastric cancer. The
patients were taught to keep in mind that they should
have half amount of soft meal six times a day for
1 month after surgery. And thereafter they can eat regu-
lar meals but we usually recommend to eat small, fre-
quent meals(about two hourly) for quite a long time.
Statistical analysis
Continuous data were expressed as the mean ± standard
deviation. For inter-subgroup comparison, the mean
values were analyzed using repeated measures ANOVA
(adjusted for preoperative values) with a post-hoc Holm-
Bonferroni method test. If Mauchly’s test of sphericity
was violated, the Greenhouse-Geisser correction was ap-
plied. All of the parameters were subjected to logarith-
mic transformation, which transformed values whichwere then converted to their original units by back-
transformation based on exponentiation. The independ-
ent factors associated with correction of lipid profiles
were evaluated by statistics carried out using univariate
and multivariable logistic regression models. A final data
analysis was performed using SPSS software (version
12.0; SPSS, Chicago, Ill). The critical p value for signifi-
cance was set at 0.05.
Results
The baseline characteristics of the patients are listed in
Table 1. Among the 144 patients, 92 (64%) were men,
whose mean BMI mean levels of TC, TG, HDL and LDL
were 23.67 kg/m2, 183.89 mg/dl, 94.87 mg/dl, 47.23 mg/
dl and 107.25 mg/dl, respectively. Over the course of the
12-month follow, the BMI and lipid profile changed at
particular time points (Table 2) (Figure 1). The mean TC
level had significantly decreased 6 months postopera-
tively, from 183. 89 ± 2.84 to 162.66 ± 3.56 mg/dl (P <
0.0001), but remained stagnant thereafter. The mean
HDL level had increased significantly 12 months postop-
eratively, from 47.23 ± 1.01 to 50.40 ± 1.00 mg/dl(P <
0.0012). There was also a significant decrease in the
LDL level 6 months postoperatively, from 107.25 ± 2.75
to 86.00 ± 2.59 mg/dl (P < 0.0001), followed by a signifi-
cant increase 12 months postoperatively to 93.65 ±
2.43 mg/dl(P < 0.0001). However, no significant changes
of TG level were observed either 6 or 12 months after
surgery.
We next compared the lipid-profile changes accord-
ing to the reconstruction type. No differences in TC,
TG or LDL level were apparent for the reconstruction
types either 6 or 12 months after surgery. The level of
HDL, by contrast, was significantly lower in patients
who had undergone Roux-en-Y (RY) reconstruction
than in those who had undergone Billroth I or II
12 months after surgery (P = 0.0098) (Figure 2).
We also compared the lipid-profile changes according to
the resection extent. Once again, no differences in TC, TG
or LDL level were evident between the total and subtotal
gastrectomy cases either 6 or 12 months after surgery. The
level of HDL, however, was significantly lower in patients
who had undergone total gastrectomy than in those who
had undergone subtotal gastrectomy both 6 (P = 0.0422)
and 12 months (P = 0.0464) after surgery (Figure 3).
We subsequently analyzed the independent factors asso-
ciated with correction of abnormal lipid profile using logis-
tic regression models. There were 49, 55, 120 and 93
patients who showed abnormal preoperative TC, TG, HDL
and LDL levels, respectively (Table 3). There were no inde-
pendent clinical factors associated with the correction of
abnormal TC, TG or HDL. But for the correction of abnor-
mal LDL, there were significant associations with gender
[OR = 0.39, 95% CI = 0.153-0.847, P = 0.0369], extent of
Table 1 Baseline characteristics of patients
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type of reconstruction [OR = 0.4.47, 95% CI = 1.01-19.68,
P = 0.0143] on multivariate analysis (Table 4).
Finally, we examined the correlations between the pa-
tients’ LDL levels and their baseline characteristics by
Spearman correlation analysis. Changes of LDL were as-
sociated with weight loss in all patients 6 months after
surgery (r = 0.17, P = 0.0433), and this association was
significant in the patients who had undergone subtotal
gastrectomy (r = 0.23, P = 0.0196). In the patients who
had undergone total gastrectomy, the change of LDL
from 6 to 12 months postoperatively also was related toweight loss (r = 0.40, P = 0.0117). The change of LDL
from 6 to 12 months postoperatively in the patients who
had undergone B-I reconstruction, meanwhile, was asso-
ciated with both BMI (r = 0.40, P = 0.0124) and FBS (r =
0.47, P = 0.0317). The LDL change from 6 to 12 months
postoperatively in those who had undergone RY recon-
struction was associated with weight loss(r = 0.35, P = 0.02)
(Figure 4).
Discussion
A number of patients who have undergone gastrectomy
for gastric cancer have experienced metabolic changes.
These include weight loss, fat malabsorption, hormonal
change and disturbance of carbohydrate metabolism.
The pathogenesis of these changes is complex, involv-
ing potentially interacting factors such as type of oper-
ation, extent of gastric resection, and patients’ eating
habits [16,17]. In the present study, we evaluated the
lipid-profile trends in gastric cancer patients who had
undergone gastrectomy and hypothesized that lipid-
profile changes would be associated with several factors
such as reconstruction type, resection extent, and
others.
With respect to the extent of gastric resection, statisti-
cally significant differences in the changes of BMI and
HDL cholesterol levels were noted between the two
groups. Although the BMI in both groups showed a
downward trend, the change was more marked in the
patients who had undergone total gastrectomy. Corres-
pondingly, the HDL cholesterol increased in both groups
with time, but the total gastrectomy group showed a
more significant change than did the subtotal group.
After total gastrectomy, the loss of gastric reservoir
space reduces caloric intake, whereas after subtotal gas-
trectomy, reservoir function can be restored, with food
intake gradually becoming normalized. Still, Liedman
et al. [18] reported that post-gastrectomy weight loss is
due to loss of fat, and concluded that malabsorption of
fat does not differ between those having a gastric
remnant and those who do not. Jagat et al. [19] found
that weight loss after subtotal gastrectomy does not sig-
nificantly differ according to resected stomach volume,
which was greater in their patients who had a higher
preoperative BMI.
Taking the types of reconstruction into account, BMI
decreased and HDL cholesterol increased in all three
groups, though the change in the RY group was more
significant than those in the B-I and B-II groups. Tanaka
et al. [20] reported that visceral fat loss after RY is larger
than that after B-I, due to an association of duodenal
bypass with loss of visceral fat. Wang et al. [10] ex-
plained that B-I reconstruction, which carries anatomic
and physiologic advantages, is associated with postoper-
ative weight recovery. Hyroyuki et al. [21] emphasized
Figure 1 Alterations of metabolic parameters 6 and 12 months after gastrectomy in all cohorts (*P < 0.05).
Table 2 The changes in metabolic parameters at the end of the 12 month study
post hoc Holm–Bonferroni method test
pre op 6 month 12 month p value (pre-6 m) p value (pre-12 m) p value (6 m-12 m) p value
TC 183.89 ± 2.84 162.66 ± 3.56 166.22 ± 3.76 <0.0001 <0.0001 <0.0001 0.4042
TG 94.87 ± 4.66 91.14 ± 3.51 96.29 ± 3.70 0.3790
HDL 47.23 ± 1.01 48.73 ± 1.05 50.40 ± 1.00 0.0225 0.1235 0.0012 0.0866
LDL 107.25 ± 2.75 86.00 ± 2.59 93.65 ± 2.43 <0.0001 <0.0001 <0.0001 <0.0001
weight 62.61 ± 0.87 57.08 ± 0.78 57.30 ± 0.79 <0.0001 <0.0001 <0.0001 0.3465
BMI 23.67 ± 0.25 21.58 ± 0.23 21.67 ± 0.23 <0.0001 <0.0001 <0.0001 0.3483
FBS 105.94 ± 2.09 102.17 ± 1.53 103.20 ± 1.98 0.2435
Data are presented as mean ± SD, TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; BMI,
body mass index; FBS, fasting blood sugar.
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Figure 2 Subgroup analysis of metabolic parameters 6 and 12 months after gastrectomy by reconstruction type (*B-I vs. RY, †B-I vs. B-II,
and ‡B-II vs. RY (P < 0.05)).
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fat digestive and absorption functions, noting that B-I
reconstruction allows for the physiologic passage of
ingested food through the duodenum.
In our analysis of the association between clinicopatho-
logic factors and lipid-profile resolution, the male gender,
total gastrectomy and RY reconstruction were found to be
correlated with the probability of LDL resolution after sur-
gery (Table 4). Also, a Spearman’s correlation analysis
showed that the LDL changes were associated with weight
reduction (Figure 4). Nguyen et al. [17] reported that
weight reduction after bariatric surgery is very effective for
achieving TC, TG, LDL declines with increased favorable
lipoprotein (HDL).
There have been some suggestions that hyperlipid-
emia can result in depression of cellular immunity and
an increased possibility of malignant transformation[22]. Dilman et al. [23] reported that disturbance of lipid
metabolism causes tumor growth and hinders DNA re-
pair, and suggested dietary and pharmacological means
of lipid metabolism correction in cancer prophylaxis
and therapy. Kim et al. [24] reported that because hyper-
cholesterolemia is a risk factor for gastric dysplasia as
well as an important prognostic factor, control of lipid
profiles can improve the therapeutic efficacy of gastric
cancer treatments. In this light, changes of lipid profiles
after radical gastrectomy for gastric cancer should be
closely monitored, and patients with persistent hyper-
lipidemia should be considered for further management
such as dietary modification or administration of lipid-
lowering agents. In any case, further study on the rela-
tionship between post-gastrectomy metabolic change
and oncologic results such as recurrence and survival is
required.
Figure 3 Subgroup analysis of metabolic parameters 6 and 12 months after gastrectomy by resection extent (*P < 0.05).
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for gastric cancer have been increased. As a result, spe-
cific concerns were raised in quality of life after radical
gastrectomy for gastric cancer as the number of long-
term survivors has increased. Furthermore, the incidence
of obesity and hyperlipidemia has been steadily increas-
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Table 4 Analysis of clinicopathologic factors associated with resolution of LDL-cholesterol at 6 month
Abnormal→ Abnormal (n = 45) Abnormal→Normal (n = 48) OR (95% CI) p value Adjust OR (95% CI) p value
Sex
Male 21(46.67) 34(70.83) 1 1
Female 24(53.33) 14(29.17) 0.36(0.153–0.847) 0.0192 0.39(0.16–0.95) 0.0369
Age (years)
Mean(SD) 58.71(8.56) 57.85(11.28) 1
Median(range) 61.00(38.00–73.00) 58.00(36.00–81.00) 0.99(0.95–1.03) 0.6786
Stage
IA 37(82.22) 23(47.92) 1
IB 2(4.44) 5(10.42) 4.02(0.72–22.47) 0.9480
IIA 1(2.22) 3(6.25) 4.83(0.47–49.22) 0.9534
IIB 2(4.44) 6(12.5) 4.83(0.90–25.97) 0.9534
IIIA 1(2.22) 3(6.25) 4.83(0.47–49.22) 0.9534
IIIB 5(10.42) Inf 0.9148
IIIC 2(4.17) Inf 0.9435
Comorbidity
No 23(51.11) 19(39.58) 1
Yes 22(48.89) 29(60.42) 1.60(0.70–3.63) 0.2654
DM
No 42(93.33) 39(81.25) 1
Yes 3(6.67) 9(18.75) 3.23(0.82–12.81) 0.0952
HBP
No 35(77.78) 36(75) 1
Yes 10(22.22) 12(25) 1.17(0.45–3.05) 0.7529
Op approach
Open 35(77.78) 40(83.33) 1
Laparoscopic 10(22.22) 8(16.67) 0.70(0.25–1.97) 0.4992
Resection extent
Total 8(17.78) 19(39.58) 1 1
Subtotal 37(82.22) 29(60.42) 0.33(0.13–0.86) 0.0234 0.36(0.14–0.97) 0.0438
Reconstruction
B-I 8(17.78) 4(8.33) 1 1
B-II 29(64.44) 22(45.83) 1.52(0.41–5.69) 0.3491 1.38(0.36–5.32) 0.3663
RY 8(17.78) 22(45.83) 5.50 (1.29–23.39) 0.0050 4.47(1.01–19.68) 0.0143
Statistics were carried out using univariate and multivariable logistic regression. Use of univariate analyses to select variables for multivariable models (P <0.05). B-I, Billorth I;
B-II, Billroth II; RY, Roux en Y.
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up strategies.
This study has several limitations. First, there might
have been a selection bias rooted in the fact that this
was a retrospective analysis. Second, the enrolled pa-
tients were not metabolically even or uniform; and
moreover, they had gastric cancers of differing hist-
ology, stage, and location, which oncologic variety
might have had an effect on the results. Third, the effect
of gut hormones was not supported by the laboratoryexamination results. Finally, it would have been helpful
if we had checked apolipoprotein A1 and B. Apolipo-
protein A1 and B are the major protein components of
HDL and LDL, respectively, and are well known bio-
markers for prediction of cardiovascular diseases. We
should’ve checked these factors, however, we do not
routinely measure them for patients with gastric cancer.
A large-scale prospective study including these labora-
tory test is needed to evaluate the mechanism of these
results.
Figure 4 Correlations between baseline characteristics and LDL-cholesterol. The data are presented as Spearman’s rank correlation
coefficients (p values).
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In conclusion, 12 months after surgery, significant
weight loss and changes in the levels of TC, LDL and
HDL were noted, whereas the level of TG remained un-
changed. The HDL level differed in accordance with
both the reconstruction type and the resection extent.
Total gastrectomy and RY reconstruction had the more
significant impacts on the lipid-profile changes. The
male gender, total gastrectomy and RY reconstruction
were all associated with the probability of correction of
abnormal LDL after surgery, and the change of LDL
level was correlated with weight loss. Close follow up
and strict control of lipid levels are recommended for
gastric cancer patients with hyperlipidemia after radical
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